Commission Implementing Regulation (EU) 2023/515 of 8 March 2023 renewing the approval of the active substance abamectin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)
Articolo 2Amendments to Implementing Regulation (EU) No 540/2011
In vigore · versione del 12 mar 2023
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.